Blockade of KCa3.1 Attenuates Left Ventricular Remodeling after Experimental Myocardial Infarction

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1305-1315

  Ju, Chen Hui ^a   Wang, Xian Pei ^a   Gao, Chuan Yu ^a,b   Zhang, Shuang Xia ^a   Ma, Xing Hua ^a   Liu, Chang ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Institute of Cardiovascular Epidemiology   (China)

Author keywords

Fibroblasts; KCa3.1; Myocardial infarction; TRAM 34; Ventricular remodeling

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; ANGIOTENSIN II; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; COLLAGEN; KCNN4 PROTEIN, MOUSE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FIBROBLAST; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE REMODELING; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; MYOFIBROBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIAC MUSCLE; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; FIBROSIS; HEART; HEART VENTRICLE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY;

ANIMALS; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; FIBROSIS; HEART; HEART VENTRICLES; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PYRAZOLES; VENTRICULAR REMODELING;

EID: 84936970920     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430298     Document Type: Article

References (32)

1. Sutton MGSJ, Sharpe N: Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy. Circulation 2000;101:2981-2988.
2. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA: Controversies in ventricular remodelling. Lancet 2006;367:356-367.
3. Weber KT, Sun Y, Tyagi SC, Cleutjens JP: Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994;26:279-292.
4. Li X, Li F, Chu Y, Wang X, Zhang H, Hu Y, Zhang Y, Wang Z, Wei X, Jian W, Zhang X, Yi F: Nod2 deficiency protects against cardiac remodeling after myocardial infarction in mice. Cell Physiol Biochem 2013;32:1857-1866.
5. Zannad F, Alla F, Dousset B, Perez A, Pitt B: Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: Insights from the randomized aldactone evaluation study (rales). Rales investigators. Circulation 2000;102:2700-2706.
6. Porter KE, Turner NA: Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther 2009;123:255-278.
7. Chen W, Frangogiannis NG: Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta 2013;1833:945-953.
8. Mishina H, Watanabe K, Tamaru S, Watanabe Y, Fujioka D, Takahashi S, Suzuki K, Nakamura T, Obata JE, Kawabata K, Yokota Y, Inoue O, Murakami M, Hanasaki K, Kugiyama K: Lack of phospholipase a2 receptor increases susceptibility to cardiac rupture after myocardial infarction. Circ Res 2014;114:493-504.
9. Wulff H, Castle NA: Therapeutic potential of kca3. 1 blockers: Recent advances and promising trends. Exp Rev Clin Pharmacol 2010;3:385-396.
10. Lu FH, Fu SB, Leng X, Zhang X, Dong S, Zhao YJ, Ren H, Li H, Zhong X, Xu CQ, Zhang WH: Role of the calcium-sensing receptor in cardiomyocyte apoptosis via the sarcoplasmic reticulum and mitochondrial death pathway in cardiac hypertrophy and heart failure. Cell Physiol Biochem 2013;31:728-743.
11. Grgic I, Kiss E, Kaistha BP, Busch C, Kloss M, Sautter J, Muller A, Kaistha A, Schmidt C, Raman G, Wulff H, Strutz F, Grone HJ, Kohler R, Hoyer J: Renal fibrosis is attenuated by targeted disruption of kca3. 1 potassium channels. Proc Natl Acad Sci U S A 2009;106:14518-14523.
12. Huang C, Shen S, Ma Q, Gill A, Pollock CA, Chen XM: Kca3. 1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrol, dialysis, transplant 2014;29:313-324.
13. Cruse G, Singh SR, Duffy SM, Doe C, Saunders R, Brightling CE, Bradding P: Functional kca3. 1 k+ channels are required for human fibrocyte migration. J Allergy Clin Immunol 2011;128:1303-1309 e1302.
14. Roach KM, Duffy SM, Coward W, Feghali-Bostwick C, Wulff H, Bradding P: The k+ channel kca3. 1 as a novel target for idiopathic pulmonary fibrosis. PloS one 2013;8:e85244.
15. White DA, Su Y, Kanellakis P, Kiriazis H, Morand EF, Bucala R, Dart AM, Gao XM, Du XJ: Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction. J Mol Cell Cardiol 2014;69:32-42.
16. Zhao N, Dong Q, Fu XX, Du LL, Cheng X, Du YM, Liao YH: Acacetin blocks kv1. 3 channels and inhibits human t cell activation. Cell Physiol Biochem 2014;34:1359-1372.
17. Zhang H, Wu J, Dong H, Khan SA, Chu ML, Tsuda T: Fibulin-2 deficiency attenuates angiotensin ii-induced cardiac hypertrophy by reducing transforming growth factor-beta signalling. Clin Sci 2014;126:275-288.
18. Yan X, Shichita T, Katsumata Y, Matsuhashi T, Ito H, Ito K, Anzai A, Endo J, Tamura Y, Kimura K, Fujita J, Shinmura K, Shen W, Yoshimura A, Fukuda K, Sano M: Deleterious effect of the il-23/il-17a axis and gammadeltat cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc 2012;1:e004408.
19. Pfeffer JM, Fischer TA, Pfeffer MA: Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Ann Rev Physiol 1995;57:805-826.
20. Gardos G: The function of calcium in the potassium permeability of human erythrocytes. Biochim Biophys Acta 1958;30:653-654.
21. Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J: A novel gene, hkca4, encodes the calcium-activated potassium channel in human t lymphocytes. J Biol Chem 1997;272:32723-32726.
22. Joiner WJ, Wang LY, Tang MD, Kaczmarek LK: Hsk4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci U S A 1997;94:11013-11018.
23. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J: A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci U S A 1997;94:11651-11656.
24. Saito T, Fujiwara Y, Fujiwara R, Hasegawa H, Kibira S, Miura H, Miura M: Role of augmented expression of intermediate-conductance ca2+-activated k+ channels in postischaemic heart. Clin Exp Pharmacol Physiol 2002;29:324-329.
25. Di L, Srivastava S, Zhdanova O, Ding Y, Li Z, Wulff H, Lafaille M, Skolnik EY: Inhibition of the k+ channel kca3. 1 ameliorates t cell-mediated colitis. Proc Natl Acad Sci U S A 2010;107:1541-1546.
26. Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, Pratt PF, Hatoum OA, Gutterman DD, Harder DR, Miura H: The intermediate-conductance calcium-activated potassium channel kca3. 1 contributes to atherogenesis in mice and humans. J Clin Invest 2008;118:3025-3037.
27. Virag JI, Murry CE: Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 2003;163:2433-2440.
28. Sun Y, Weber KT: Infarct scar: A dynamic tissue. Cardiovas Res 2000;46:250-256.
29. Lijnen PJ, van Pelt JF, Fagard RH: Downregulation of manganese superoxide dismutase by angiotensin ii in cardiac fibroblasts of rats: Association with oxidative stress in myocardium. Am J Hypertens 2010;23:1128-1135.
30. Zhang W, Chen XF, Huang YJ, Chen QQ, Bao YJ, Zhu W: 2,3,4',5-tetrahydroxystilbene-2-o-beta-d-glucoside inhibits angiotensin ii-induced cardiac fibroblast proliferation via suppression of the reactive oxygen species-extracellular signal-regulated kinase 1/2 pathway. Clin Exp Pharmacol Physiol 2012;39:429-437.
31. Borg TK, Ranson WF, Moslehy FA, Caulfield JB: Structural basis of ventricular stiffness. Lab Invest 1981;44:49-54.
32. Xu CW, Zhang TP, Wang HX, Yang H, Li HH: Chip enhances angiogenesis and restores cardiac function after infarction in transgenic mice. Cell Physiol Biochem 2013;31:199-208.